Clin Mol Hepatol.
2025 Jan;31(1):e19-e20. 10.3350/cmh.2024.0906.
Chronic hepatitis B, extrahepatic malignancies and the use of antiviral drugs
- Affiliations
-
- 1Division of Pediatric Gastroenterology, Children’s Medical Center, Taichung Veterans General Hospital, Taichung, Taiwan
- 2Department of Post- Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan
- 3School of Medicine, Chung Shan Medical University, Taichung, Taiwan
- 4Education Center, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan
- 5Department and Graduate Institute of Business Administration, National Taiwan University, Taipei, Taiwan
- 6Department of Pharmacology, Chung Shan Medical University, Taichung, Taiwan
- 7Orthopedics Department, Chi-Mei Medical Center, Tainan, Taiwan
- KMID: 2563447
- DOI: http://doi.org/10.3350/cmh.2024.0906
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Nucleos(t)ide analog therapy of chronic hepatitis B and extrahepatic cancer risk: Is tenofovir better than entecavir?: Editorial on “Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort study”
- New antiviral agents for treatment of chronic hepatitis B
- Anti-viral Treatment of Chronic Hepatitis B
- Monitoring and Treatment Strategy for Chronic Hepatitis B and Antiviral Resistant Hepatitis B
- Efficacy of New Anti-viral Agent in the Treatment of Chronic Hepatitis B
